Quarterly report pursuant to Section 13 or 15(d)

Line of Credit (Details Narrative)

v3.19.2
Line of Credit (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Aug. 14, 2019
Jun. 30, 2019
Nov. 13, 2018
Subsequent Event [Member]      
Line of credit outstanding accounts receivable $ 325,000    
Line of credit facility, description The Company has drawn $3.4 million of the $4.0 million of available funds under its Revolving Line; $250,000 of the Line of Credit has been used to secure the issuance of a LOC by SVB. As such, the amount available under the line is $3.75 million. The funds drawn were used in conjunction with the acquisition of the BioPharma Business of CGI.    
Silicon Valley Bank [Member]      
Line of credit facility, description   The amount that may be borrowed under the Revolving Line is the lower of (i) $4.0 million or (ii) 80% of the Company’s eligible accounts receivable (as adjusted by SVB). Revolving Line outstanding amounts incur interest at a rate per annum equal to the Wall Street Journal Prime Rate plus 0.5%. The Company is also required to pay an unused Revolving Line facility fee monthly in arrears in an amount equal to 0.35% per annum of the average unused but available portion of the Revolving Line. Subsequent to June 30, 2019, the Company has drawn $3.4 million of the available funds with the Revolving Line.  
Revolving Line facility fee monthly in arrears, percentage   0.35%  
Silicon Valley Bank [Member] | Subsequent Event [Member]      
Line of credit outstanding accounts receivable $ 325,000    
Withdrawn of available funds $ 3,400,000    
Silicon Valley Bank [Member] | Prime Rate [Member]      
Line of credit, percentage   0.50%  
Loan and Security Agreement [Member] | Silicon Valley Bank [Member]      
Line of credit     $ 4,000,000
Line of credit outstanding accounts receivable     4,000,000
Loan and Security Agreement [Member] | Silicon Valley Bank [Member] | Term Loan [Member]      
Line of credit     $ 850,000